Subcutaneous Implants of Buprenorphine-Cholesterol-Triglyceride Powder in Mice

Table 4

Weight change in male and female mice, 3 and 15 mg/kg dose of buprenorphine drug powder.

Day	Female mice ()			Male mice ()
	Control	1x dose	5x dose	Control	1x dose	5x dose
	Avg ± St Dev	Avg ± St Dev	Avg ± St Dev	Avg ± St Dev	Avg ± St Dev	Avg ± St Dev
0	18.0 ± 0.5	17.9 ± 0.4	18.6 ± 0.7	21.3 ± 1.0	21.7 ± 0.9	19.3 ± 1.0
4	17.6 ± 0.8	16.6 ± 0.5	17.5 ± 0.5	21.4 ± 1.3	19.8 ± 2.3	18.6 ± 1.2